Australia markets closed

Seneca Growth Capital VCT plc (HYG.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
13.500.00 (0.00%)
As of 09:00PM BST. Market open.
Full screen
Previous close0.00
YTD returnN/A
Expense ratio (net)N/A
CategoryN/A
Last cap gainN/A
Morningstar ratingN/A
Morningstar risk ratingN/A
Sustainability ratingN/A
Net assetsN/A
Beta (5Y monthly)N/A
YieldN/A
5y average returnN/A
Holdings turnoverN/A
Last dividendN/A
Average for categoryN/A
Inception dateN/A
  • GlobeNewswire

    B Share Net Asset Value

    Net Asset Value(s) Seneca Growth Capital VCT Plc (the "Company") 1 May 2024 B Share Net Asset Value The Directors and the Investment Manager of the Company, Seneca Partners Limited, have reviewed the valuation of the Company's B share portfolio as at 29 April 2024. The unaudited net asset value per B share ("NAV") as at 29 April 2024 was 60.8p per share. This represents a reduction of 2.9p from the previously published unaudited NAV as at 31 March 2024. We have reviewed the Ordinary share portfo

  • GlobeNewswire

    Share Buy-back and Total Voting Rights

    Seneca Growth Capital VCT Plc – Transaction in Own Shares Seneca Growth Capital VCT Plc (“The Company”) Share Buy-back and Total Voting Rights The Board of Seneca Growth Capital VCT Plc announces that on 18 April 2024 the Company purchased for cancellation 125,232 B Ordinary Shares of 1p at a gross price of 60.52p per share. In accordance with the FCA's Disclosure and Transparency Rules sourcebook transitional provision 6, the Company advises that, following this purchase for cancellation, its c

  • GlobeNewswire

    Issue of Equity and Total Voting Rights

    Seneca Growth Capital VCT Plc (the "Company") 5 April 2024 Issue of Equity and Total Voting Rights The Company announces that it has today allotted and issued 1,232,218 new B ordinary shares of 1p each in the Company (“B Shares”). The shares were issued pursuant to an offer for subscription for B Shares launched on 24 August 2023 to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the "Offer"). Pursuant to the Offer, and